Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health and Human”

1,164 pharma patents match "The United States of America, as represented by the Secretary, Department of Health and Human" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,164
Index total 30,257
Page 15 / 49

Quick answer

This filtered view shows 1,164 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health and Human" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,164 results for “The United States of America, as represented by the Secretary, Department of Health and Human” · 30,257 patents in full index Clear search

  1. US 10940188

    Compounds and methods for treatment and prevention of Flavivirus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted

  2. US 10925874

    Substituted pyrazolopyrimidines as glucocerebrosidase activators

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted

  3. US 10925969

    Anti-BCMA polypeptides and proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted

  4. US 10913711

    Potent and selective inhibitors of monoamine transporters; method of making; and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted

  5. US 10913785

    Anti-human papillomavirus 16 E6 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted

  6. US 10913709

    STAT3 inhibitor formulation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted

  7. US 10912797

    Tumor infiltrating lymphocytes and methods of therapy

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Feb 9, 2021 · Expires Feb 4, 2041

    granted

  8. US 10907151

    Compositions and methods for treating or preventing lupus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted

  9. US 10906940

    Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted

  10. US 10906914

    Furoquinolinediones as inhibitors of TDP2

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted

  11. US 10905769

    Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted

  12. US 10899710

    Pyridines and their use in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted

  13. US 10900042

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted

  14. US 10898566

    Zika virus vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted

  15. US 10894966

    Virus-based expression vectors and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted

  16. US 10894077

    Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted

  17. US 10881669

    Inhibitors of the plasmodial surface anion channel as antimalarials

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted

  18. US 10881653

    Tricyclic compounds and their use in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted

  19. US 10882886

    Adeno-associated virus polynucleotides, polypeptides and virions

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (WASHINGTON DC) · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted

  20. US 10876003

    Class of stable heptamethine cyanine fluorophores and biomedical applications thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  21. US 10875860

    Azaindenoisoquinoline compounds and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  22. US 10876123

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  23. US 10869856

    Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  24. US 10870687

    Anti-human papillomavirus 16 E7 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.